S. Africa court mulls AIDS drugs defamation

	Tweet

A South African court reserved judgment on Tuesday on an attempt by the country’s most influential AIDS activist group to block an AIDS “dissident” from labelling it a front for pharmaceutical companies.

German doctor Matthias Rath and his Rath Foundation have accused the Treatment Action Campaign (TAC) - which has long fought the South African government for free anti-AIDS drugs - of being a front for drug companies eager to sell their products.

“These are liars who are defending lies as free speech,” said TAC chairman Zackie Achmat, who was nominated for a Nobel Prize last year.

"Our constitution protects free speech but not the right to lies,” he said, adding he was fairly confident of winning a court injunction that would stop Rath from disparaging the TAC.

Rath says life-prolonging antiretroviral drugs are toxic and the deadly disease can be better treated through multivitamins he sells.

His foundation has taken out newspaper advertisements and spread leaflets in poor South African townships accusing the United States, Britain, the United Nations and the World Health Organisation of a conspiracy to promote expensive medicines on behalf of a drugs cartel.

The TAC denies it has ever received money from drug companies, and says accusations like Rath’s are dangerously misleading for millions of South Africans with HIV/AIDS.

South Africa is the country hardest hit by AIDS, with one in nine of its 45 million population estimated to carry the HIV virus that causes the disease. Only about 42,000 of them are now receiving publicly funded AIDS drugs.

Judge Siraj Desai said a full bench of the court would make its ruling within “the next few weeks”. 

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]